Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

FP5

SPAVACC Informe resumido

Project ID: QLK2-CT-1999-00983
Financiado con arreglo a: FP5-LIFE QUALITY
País: United Kingdom

New and improved recombinant JSRV proteins

A number of different new plasmid constructs were made for the expression of recombinant JSRV proteins. Expression and purification of the proteins was optimised and the proteins were used as immunogens or as antigens for immunological assays. The proteins have further use for similar studies. In the right dose, adjuvant and immunisation route one or more of the proteins may be a component of a future vaccine against OPA. The same proteins could also be employed in assays to monitor vaccine efficacy in inducing immune responses.

Contacto

Christina COUSENS, (Senior Scientist)
Tel.: +44-131-4455111
Fax: +44-131-4456111
Correo electrónico
Síganos en: RSS Facebook Twitter YouTube Gestionado por la Oficina de Publicaciones de la UE Arriba